We continuously seek to expand from our core science base in ways that complements our company’s portfolio and thus have invested into Next Generation Sequencing and associated bioinformatics technologies in recent years. Through these capabilities, we are able to offer these in conjunction with our Drosophila models or as a standalone service package.